Rheumatic Heart Disease: Case Discussion & Key Learning Points
Model Case Presentation
Patient Demographics
Name: Miss Priya, Age: 10 years, Gender: Female, Informant: Mother (Reliable)
Chief Complaints
- Breathlessness on exertion – 6 months
- Swelling of both feet – 2 months
- Recurrent sore throat and joint pains – over 2 years
History Summary
The child had two episodes of fever with migratory polyarthritis involving knees and ankles over the past 2 years, both following sore throat. Was treated with antibiotics each time. Currently, she develops breathlessness on climbing stairs (NYHA Class II), and has noticed bilateral ankle swelling. No squatting, no cyanosis, no syncope.
First episode 2 years ago: fever, swollen painful right knee, then left ankle (migratory), treated at a local clinic as "joint infection." No throat swab done. No penicillin prophylaxis started. Second episode 10 months ago: similar, with fever and palpitations. Echo done at that time — mild mitral regurgitation noted. No follow-up maintained.
No family history of CHD. No consanguinity. Lives in a cramped chawl with 6 family members in one room (overcrowding — risk factor).
Examination Summary
| Parameter | Finding | Significance |
|---|---|---|
| Pulse | 92/min, irregular | Atrial fibrillation (chronic RHD) |
| BP | 90/60 mmHg | Low — reduced cardiac output (MS) |
| JVP | Raised 4 cm above sternal angle | Right heart failure / elevated LAP transmitted |
| SpO2 | 95% on room air | Mild hypoxemia |
| Malar flush | Present | Classic sign of mitral stenosis |
| Bilateral pedal edema | Present (pitting) | Congestive heart failure |
Precordium: Tapping apex beat at 5th ICS-MCL (not displaced). Parasternal heave (RV hypertrophy). Diastolic thrill at apex in left lateral position.
Auscultation: Loud S1. Opening snap (OS) after S2. Low-pitched rumbling mid-diastolic murmur (MDM) with presystolic accentuation at apex, best heard in left lateral position with bell. Pansystolic murmur at apex radiating to axilla (mitral regurgitation component). Loud P2 (pulmonary hypertension).
Other systems: Bilateral basal crepitations. Hepatomegaly 3 cm, tender. Spleen not palpable.
✅ Complete Diagnosis
Rheumatic Heart Disease — Combined Mitral Valve Disease (Mitral Stenosis + Mitral Regurgitation), with Atrial Fibrillation, Pulmonary Arterial Hypertension, and Congestive Heart Failure (NYHA Class III), secondary to Recurrent Acute Rheumatic Fever (2 episodes), with no secondary prophylaxis.
📝 History — Exam Q&A
Rheumatic Heart Disease (RHD) is permanent damage to the heart valves resulting from one or more episodes of Acute Rheumatic Fever (ARF). ARF is a delayed autoimmune inflammatory sequela of Group A Beta-Hemolytic Streptococcal (GABHS) pharyngitis, occurring in genetically susceptible individuals. The immune response to streptococcal M-protein antigens cross-reacts with cardiac tissue (molecular mimicry), causing valvulitis → valve scarring → stenosis and/or regurgitation over years.
💡 Classic Teaching
"Rheumatic fever licks the joints and bites the heart" — Laseque, 1884. Arthritis is self-limiting; carditis is the permanent damage.
ARF most commonly affects children aged 5–15 years. RHD (the chronic sequela) manifests in young adults aged 20–40 years. Tight mitral stenosis and Sydenham's chorea are more common in females. Aortic stenosis from RHD tends to be more common in males.
Diagnosis: 2 Major criteria OR 1 Major + 2 Minor criteria + evidence of preceding GABHS infection.
| Low-Risk Population | Moderate/High-Risk Population (e.g., India) | |
|---|---|---|
| Major Criteria (CASES) |
Carditis (clinical and/or subclinical/echocardiographic) Arthritis — Polyarthritis only Sydenham's Chorea Erythema Marginatum Subcutaneous Nodules |
|
| Arthritis — extra | Only polyarthritis | Polyarthritis OR monoarthritis OR polyarthralgia |
| Minor Criteria | Fever ≥38.5°C, ESR ≥60 mm/hr and/or CRP ≥3 mg/dL, Prolonged PR interval | Fever ≥38°C, ESR ≥30 mm/hr and/or CRP ≥3 mg/dL, Prolonged PR interval, Monoarthralgia |
Evidence of preceding GABHS infection: Elevated ASO titer / Anti-DNase B, positive throat culture, or positive rapid strep antigen test.
💡 Key 2015 Changes
1. Echocardiographic (subclinical) carditis now counts as a major criterion. 2. Low-risk vs moderate/high-risk population distinction introduced. 3. Polyarthralgia is a major criterion in moderate/high-risk populations. 4. Echo recommended in ALL suspected ARF cases.
Subclinical carditis refers to Doppler echocardiographic evidence of mitral and/or aortic valve regurgitation meeting pathological criteria, in the absence of any auscultatory murmur. The 2015 Jones criteria elevated it to a major criterion because echocardiography detects carditis 10× more frequently than auscultation alone in endemic areas. It is important because undetected carditis means no secondary prophylaxis is started, leading to progressive valve damage with recurrences.
| Feature | ARF Arthritis | Septic Arthritis | JIA |
|---|---|---|---|
| Type of joints | Large joints (knee, ankle, wrist, elbow) | Usually single joint | Variable (small + large) |
| Pattern | Migratory (moves from joint to joint) | Fixed | Additive or fixed |
| Duration per joint | Days (transient) | Days–weeks | Weeks–months (persistent) |
| Response to aspirin | Dramatic improvement (diagnostic) | Poor | Variable |
| Preceding throat infection | Yes (1–5 weeks prior) | Skin/other source | No |
| Permanent joint damage | None — fully resolves | Possible | Possible |
Sydenham's chorea (St. Vitus' dance) is the CNS manifestation of ARF — involuntary, purposeless, non-rhythmic movements of the face, limbs, and trunk, with muscle hypotonia and emotional lability.
- Occurs in 10–30% of ARF; more common in females
- Appears 1–6 months after streptococcal infection (longest latent period of all ARF manifestations)
- Often the only manifestation of ARF (pure chorea) — other signs may have resolved
- ASO titer may be normal at the time of presentation
- Signs: Milkmaid's grip (fluctuating grip), Pronator sign (hands pronate when arms extended), Jack-in-the-box tongue
- Usually self-limiting in 2–3 months; may persist up to 6 months
💡 Exam Point
Isolated chorea (without other criteria) is still sufficient for a diagnosis of ARF. Secondary prophylaxis must still be started.
Erythema Marginatum: Fleeting, non-pruritic, pink-red erythematous rash with central clearing and advancing serpiginous margins. Appears on trunk and proximal limbs (never on face). Blanches on pressure. Waxes and wanes. Seen in <5% of ARF cases.
Subcutaneous Nodules: Small (0.5–2 cm), firm, painless nodules over bony prominences (olecranon, wrists, knees, occiput, spinous processes). Found in <5% of ARF. Almost always associated with significant carditis (never appear alone).
Both are major criteria but rarely sufficient as stand-alone criteria. Their presence strongly suggests carditis is also present.
- Recurrent GABHS pharyngitis — each episode increases valve damage
- Poverty and overcrowding — facilitates streptococcal transmission
- Genetic susceptibility — certain HLA haplotypes (HLA-DR7, DR4) predispose to ARF in ~3–6% of infected individuals
- No penicillin prophylaxis — absence of secondary prophylaxis after first attack
- Age 5–15 years — peak age group
- Developing countries — poor access to strep treatment
| Valve Involvement | Frequency | Notes |
|---|---|---|
| Mitral alone (MS or MR) | ~50–60% | Most common; MR precedes MS (acute → chronic) |
| Mitral + Aortic | ~20–25% | Combined lesion common |
| Aortic alone | ~5–10% | Uncommon; usually AR or combined AS+AR |
| Tricuspid | ~10% | Always associated with mitral disease; never isolated |
| Pulmonary | <1% | Rarest; functional PR from PAH more common |
💡 Key Point
In acute ARF, regurgitation (MR/AR) is the primary lesion due to valve inflammation and edema. Stenosis (MS/AS) develops over years due to fibrosis, calcification, and commissural fusion — chronic RHD.
History of rheumatic fever / strep throat: Any previous episode of fever + joint pains? Sore throat preceding? Treatment given?
Cardiac symptoms: Breathlessness (NYHA class), palpitations, chest pain, syncope, orthopnea, PND.
Complications: Hemoptysis (MS — pink frothy or blood-stained), stroke or focal neurological deficit (systemic embolism from LA thrombus), recurrent respiratory infections (pulmonary congestion).
Compliance: Was penicillin prophylaxis started? If yes, how regularly administered?
Social history: Overcrowding, socioeconomic status (strep transmission risk).
Pertinent negatives: No cyanosis (helps exclude cyanotic CHD), no squatting spells, no syncope (differentiates from HOCM/AS).
🩺 Examination — Exam Q&A
- Malar flush (mitral facies): Bilateral pinkish-purple discoloration of malar eminences due to chronic hypoxia-induced dilation of malar capillaries — classic sign of severe mitral stenosis
- Irregular pulse: Atrial fibrillation — common complication of chronic mitral stenosis due to left atrial dilatation
- Pulse deficit: Difference between apical and radial pulse rates in AF
- Low volume pulse: In severe MS due to reduced cardiac output
- JVP raised: In heart failure or functional tricuspid regurgitation
- Peripheral edema, ascites: Right heart failure secondary to PAH
- Loud (tapping) S1: Mitral valve leaflets are thickened and immobile in the open position. They snap shut with high velocity → loud S1. S1 softens as leaflets calcify.
- Opening Snap (OS): High-pitched sound shortly after S2, heard best at apex/LLSB. Caused by sudden halting of the stenotic valve opening. Shorter S2–OS interval = more severe MS (higher LA pressure opens valve earlier).
- Low-pitched rumbling mid-diastolic murmur (MDM): Best heard at apex with bell in left lateral decubitus position (LLD), with breath held in expiration. Due to turbulent flow across narrowed mitral valve during diastole.
- Pre-systolic accentuation (PSA): MDM increases in intensity just before S1 due to atrial contraction (atrial kick). Absent in atrial fibrillation (no atrial contraction).
- Loud P2: Indicates pulmonary hypertension (common in MS).
💡 How to elicit MDM in MS
Use the BELL of the stethoscope at the apex, with the patient in the left lateral decubitus (LLD) position, after exercise (increases heart rate → more turbulence). Press lightly — heavy pressure converts bell to diaphragm.
- Pansystolic (holosystolic) murmur at apex — blowing, high-pitched, starts at S1 and continues up to S2 without gap
- Radiates to left axilla and left infrascapular area
- S1 soft (valve leaflets fail to coapt firmly)
- S3 (gallop) may be present — due to rapid ventricular filling in severe MR
- Hyperdynamic displaced apex beat (volume overload of LV)
- Mid-diastolic flow murmur at apex (if MR is severe — relative MS due to large return volume)
| Feature | Carey-Coombs Murmur (ARF) | Mitral Stenosis Murmur (chronic RHD) |
|---|---|---|
| Timing | Mid-diastolic | Mid-diastolic + presystolic accentuation |
| Cause | Active valvulitis → mitral valve thickening + severe MR causing relative MS | Fibrosed, calcified mitral valve → fixed stenosis |
| Opening snap | Absent | Present (if leaflets still pliable) |
| S1 | Normal or soft | Loud (tapping) |
| Course | Transient — disappears after acute phase resolves | Permanent, progressive |
| Context | Active ARF with carditis | Chronic RHD, years after ARF |
Murmur: Early diastolic, high-pitched, blowing murmur at left sternal border (3rd–4th ICS), best heard sitting forward, breath held in expiration.
Peripheral signs of AR (due to wide pulse pressure):
- Corrigan's pulse (water-hammer pulse) — forceful, rapidly collapsing pulse
- Quincke's sign — nail bed capillary pulsation
- De Musset's sign — head nodding with each heartbeat
- Duroziez's sign — to-and-fro murmur over femoral artery with gentle compression
- Traube's sign — pistol-shot sounds over femoral artery
- Hill's sign — popliteal BP exceeds brachial BP by >20 mmHg
- Austin Flint murmur — low-pitched mid-diastolic murmur at apex due to regurgitant jet impinging on anterior mitral leaflet (functional MS)
ARF produces pancarditis (endocarditis + myocarditis + pericarditis):
- Tachycardia out of proportion to fever — most consistent early sign of carditis
- New or changing murmur — apical pansystolic murmur (MR) and/or early diastolic murmur (AR)
- Carey-Coombs murmur at apex (active valvulitis with significant MR)
- Pericardial friction rub — pericarditis component (to-and-fro scratchy sound)
- Signs of myocarditis — S3 gallop, cardiomegaly, CCF (hepatomegaly, crepitations)
- Prolonged PR interval on ECG (minor Jones criterion — does NOT by itself indicate carditis)
🚨 Exam Trap
Prolonged PR interval is a minor criterion — it reflects myocarditis/conduction system involvement but alone does NOT constitute carditis (which requires murmur evidence of valvulitis or echo findings).
| Feature | Mitral Stenosis | Mitral Regurgitation |
|---|---|---|
| Apex beat | Tapping, not displaced (small LV) | Hyperdynamic, displaced laterally (LV volume overload) |
| Parasternal heave | Present (RV hypertrophy from PAH) | May be present if PAH develops |
| Thrills | Diastolic thrill at apex in LLD position | Systolic thrill at apex (if severe MR) |
| S1 | Loud (tapping) | Soft |
| Murmur | MDM + PSA at apex | Pansystolic at apex → axilla |
Graham-Steell murmur is a high-pitched early diastolic murmur heard at the left upper sternal border (pulmonary area) due to functional pulmonary regurgitation secondary to severe pulmonary arterial hypertension causing dilation of the pulmonary valve ring. It is not a structural pulmonary valve lesion. It is seen in advanced mitral stenosis with severe PAH. It must be differentiated from organic AR (which is heard at LLSB and associated with peripheral signs).
🔬 Investigations — Exam Q&A
| Test | Finding in ARF | Significance |
|---|---|---|
| ASO titer (Antistreptolysin O) | Elevated (>200 Todd units in adults; >320 in children) | Confirms preceding GABHS infection (rises 1–3 weeks post-infection, peaks 3–5 weeks). May be negative in chorea (late presentation) |
| Anti-DNase B | Elevated | More sensitive than ASO, especially for skin infections and chorea. Stays elevated longer. |
| ESR | Elevated (>60 mm/hr low-risk; >30 mm/hr high-risk) | Acute phase reactant — disease activity marker. Remains elevated during active carditis. |
| CRP | Elevated (>3 mg/dL) | More sensitive marker; rises and falls faster than ESR. Useful to monitor treatment response. |
| Throat culture | GABHS positive (only in ~30% at time of diagnosis) | Confirms active infection; negative culture does not exclude preceding infection |
| CBC | Leukocytosis (neutrophilia) | Non-specific; confirms acute inflammation |
| Blood culture | Negative (differentiates from infective endocarditis) | Important if IE is a differential |
| Condition | ECG Finding | Mechanism |
|---|---|---|
| Active ARF/carditis | Prolonged PR interval (1st degree AV block) | Inflammatory involvement of AV node (myocarditis). Usually resolves after acute episode. |
| Acute carditis (severe) | 2nd/3rd degree AV block (rare) | Severe myocarditis |
| Mitral Stenosis | P mitrale (broad, notched P wave, duration >0.12s, best in lead II); Prominent terminal negative P in V1 | Left atrial enlargement due to mitral obstruction |
| Mitral Stenosis (chronic) | Atrial fibrillation — irregularly irregular rhythm, absent P waves, fibrillatory baseline | LA dilatation and inflammation → arrhythmic substrate |
| Mitral Stenosis + PAH | Right axis deviation, RVH (tall R in V1, deep S in V6) | RV pressure overload from elevated PA pressure |
| Mitral Regurgitation | LVH (tall R in V5–V6, deep S in V1), P mitrale | LV volume overload; LA enlargement |
Heart:
- Straight or convex left heart border (due to prominent left atrial appendage)
- Double density shadow at right heart border (enlarged LA behind RA shadow)
- Cardiomegaly (CT ratio >0.55)
- Prominent main pulmonary artery segment (left 2nd arch)
- Splaying of carina (subcarinal angle >70°) — due to LA enlargement elevating left main bronchus
Lungs:
- Pulmonary venous hypertension: upper lobe blood diversion (antler sign)
- Kerley B lines — horizontal lines at costophrenic angles (interstitial edema, lymphatic dilatation)
- Pulmonary plethora or pulmonary edema in severe cases
- Hemosiderosis (rare, chronic) — diffuse nodular shadows from repeated pulmonary hemorrhages
2D Echocardiography with Color Doppler is the gold standard. It provides:
- Structural valve assessment: thickening, calcification, commissural fusion, subvalvular involvement
- Mitral valve area (MVA) — by planimetry or PHT method (normal MVA = 4–6 cm²)
- Severity of MR/AR by color Doppler and jet area
- Estimation of PA pressure via TR jet velocity
- Chamber dimensions: LA size (LA >45 mm = high risk of AF and thromboembolism), LV function
- Detection of thrombus (especially in LA appendage — use TEE)
- Subclinical carditis detection in ARF cases with no murmur
💡 MVA and Severity
Mitral Stenosis severity: Mild MVA >1.5 cm² | Moderate 1.0–1.5 cm² | Severe <1.0 cm²
Not routinely needed in the era of echo. Indications include:
- Discordance between clinical and echocardiographic findings
- Assessment of pulmonary vascular resistance when severe PAH is present (to determine operability)
- Concomitant coronary artery disease evaluation before surgery (in adults >40 years)
- Balloon mitral valvotomy (BMV / PTMC) — therapeutic, via interventional catheterization
💊 Management — Exam Q&A
1. Eradicate GABHS (Primary + first dose of Secondary Prophylaxis):
- Benzathine Penicillin G 1.2 million units IM (single dose) — first-line, even if throat culture is negative
- Oral Amoxicillin 50 mg/kg/day for 10 days (if IM not feasible)
- Penicillin allergy: Oral Azithromycin 12 mg/kg/day × 5 days or Cephalosporin × 10 days
2. Anti-inflammatory therapy:
- Arthritis without carditis: Aspirin 80–100 mg/kg/day (children >12 years) in 4 divided doses. Note: Avoid aspirin in children <12 years (Reye's syndrome risk) — use Naproxen 10–20 mg/kg/day instead as per current guidelines
- Moderate-severe carditis (CCF): Prednisolone 1–2 mg/kg/day (max 40–60 mg/day) × 2–3 weeks, then taper over 2–3 weeks. Anti-inflammatory taper as ESR/CRP normalize.
3. Treat CCF: Furosemide, ACE inhibitor (enalapril), strict sodium restriction, bed rest until carditis resolves.
4. Chorea: Sodium valproate or Carbamazepine (for severe, disabling chorea). Secondary prophylaxis mandatory.
Secondary prophylaxis is long-term antibiotic therapy to prevent recurrent GABHS pharyngitis and further attacks of ARF (preventing cumulative valve damage).
Gold Standard Regimen (Class I, Level A — AHA):
Benzathine Penicillin G 1.2 million units IM every 4 weeks
(Every 3 weeks in high-risk patients or those with recurrence on 4-weekly regimen, or in high-incidence settings)
Alternatives (oral — less effective, require strict compliance):
- Phenoxymethylpenicillin (Penicillin V) 250 mg twice daily orally
- Sulfadiazine 1 g/day (adults), 500 mg/day (children <30 kg)
- Penicillin allergy: Macrolide (Erythromycin 250 mg twice daily)
| Category | Duration |
|---|---|
| RHD with residual valvular disease (persistent valve lesion) | 10 years from last attack OR until age 40 years (whichever is longer). Consider lifelong in high-risk patients. |
| ARF with carditis, no residual valve disease | 10 years OR until age 21 years (whichever is longer) |
| ARF without carditis | 5 years OR until age 21 years (whichever is longer) |
🚨 Key Point
Secondary prophylaxis must continue even AFTER valve surgery (repair or replacement), because the remaining valves are still at risk from future ARF attacks.
- Secondary prophylaxis: Lifelong benzathine penicillin (as above)
- Diuretics: Furosemide + spironolactone — reduce pulmonary congestion, peripheral edema
- Rate control in AF: Digoxin, beta-blockers (metoprolol), or calcium channel blockers (diltiazem) — slowing heart rate allows longer diastolic filling time across stenotic valve
- Anticoagulation: Warfarin (INR 2–3) — mandatory in MS with AF, prior embolism, or LA thrombus. Prevents systemic thromboembolism from LA stasis.
- ACE inhibitors / ARBs: Useful if significant MR component is present (afterload reduction)
- Avoid: Vasodilators in pure MS (drop in preload → further reduces CO)
PTMC (Percutaneous Transvenous Mitral Commissurotomy) / BMV: A balloon catheter is introduced via femoral vein, transseptal puncture into LA, positioned across the mitral valve, and inflated to split fused commissures — widening the valve orifice without surgery.
Indications:
- Symptomatic (NYHA ≥ II) severe MS (MVA ≤1.5 cm²) with favorable valve morphology
- Moderate MS in patient planning pregnancy
- Asymptomatic severe MS with new-onset AF or PAH
Contraindications:
- LA thrombus (especially LA appendage — rule out by TEE)
- Significant MR (≥ moderate grade) — BMV would worsen it
- Heavily calcified or subvalvular disease (unfavorable Wilkins score >8)
- Combined severe MS + severe AR (requires surgical intervention)
💡 Wilkins Echo Score
Scoring of valve mobility, thickening, calcification, and subvalvular involvement (0–4 each = total 0–16). Score ≤8 = favorable for BMV. Score >8 = consider surgery.
- Severe symptomatic MS not amenable to BMV (unfavorable morphology, or failed BMV)
- Severe MR with LV dysfunction (LVEF <60% or LVESD >40 mm)
- Symptomatic severe AR (NYHA II–IV)
- Severe AR with LVEF <50%
- Severe combined lesions (MS + MR or MS + AR) not amenable to PTMC
- Infective endocarditis on rheumatic valve with uncontrolled infection or severe regurgitation
- Active carditis in ARF unresponsive to medical therapy with hemodynamic deterioration
Surgical options: Mitral valve repair (preferred if possible), mitral valve replacement (MVR) with mechanical or bioprosthetic valve, open mitral commissurotomy (OMC).
As per AHA 2007 guidelines, IE prophylaxis before dental procedures is NOT routinely recommended for rheumatic valvular disease without prosthetic valve or previous IE.
IE prophylaxis IS indicated for:
- Prosthetic cardiac valves (mechanical or bioprosthetic)
- History of previous IE
- Valves repaired with prosthetic material (within 6 months and if residual defect persists near prosthetic material)
🚨 Important Caveat
In patients receiving penicillin prophylaxis for ARF who require dental IE prophylaxis, use a different agent (e.g., clindamycin or azithromycin) — NOT amoxicillin — because oral streptococci in the mouth may have developed relative penicillin resistance due to ongoing penicillin exposure.
- Atrial Fibrillation — due to LA dilatation; increases thromboembolic risk 5×
- Systemic thromboembolism — stroke, splenic/renal infarcts, limb ischemia (from LA thrombus in AF)
- Pulmonary Arterial Hypertension — progressive, leads to RV failure
- Congestive Heart Failure — left then biventricular
- Infective Endocarditis — valves already damaged are susceptible to IE
- Hemoptysis in MS — due to ruptured pulmonary venous varices (acute, large — Pulmonary Apoplexy), or pulmonary edema (pink frothy), or pulmonary infarction, or chronic bronchitis
- Recurrent ARF — if prophylaxis not maintained → progressive valve damage
- Pregnancy complications — severe MS poorly tolerated; risk of maternal and fetal mortality (MVA <1.5 cm² is high risk in pregnancy)
| Level | Goal | Intervention |
|---|---|---|
| Primordial Prevention | Prevent GABHS infection in population | Improved housing, reduce overcrowding, better sanitation, future GAS vaccine |
| Primary Prevention | Treat GABHS pharyngitis before ARF develops | Prompt antibiotic treatment of strep throat (Benzathine Pen G IM or oral Amoxicillin × 10 days) |
| Secondary Prevention | Prevent recurrences of ARF after first attack; prevent progressive valve damage | Long-term benzathine penicillin G every 4 weeks |
🔭 Recent Advances — Exam Q&A
- Subclinical carditis (echo-detected) is now a major criterion, enabling earlier diagnosis and prophylaxis initiation before clinical carditis appears
- Population-risk stratification (low vs moderate/high risk) allows more sensitive diagnostic criteria in endemic areas like India — polyarthralgia is now a major criterion in high-risk populations
- Echocardiography is now recommended for ALL suspected ARF cases, even without murmur
- These changes identified up to 10× more carditis cases than auscultation alone in endemic populations
Population-based echocardiographic screening programs in high-burden countries (Sub-Saharan Africa, South Asia, Pacific Islands) have shown the prevalence of RHD is 10× higher than detected by clinical auscultation alone. Many children have "latent" or subclinical RHD — valve disease detectable only by echo without symptoms or murmur.
The 2012 World Heart Federation (WHF) guidelines defined echocardiographic criteria for pathological MR/AR to standardize RHD screening diagnoses. This enabled the concept of "screen-and-treat" programs: screen schoolchildren in endemic areas → identify subclinical RHD → start prophylaxis early.
PTMC (also called BMV) is the minimally invasive catheter-based splitting of fused mitral commissures using an Inoue balloon. The Inoue balloon technique is the most widely used.
Advantages over Open Mitral Commissurotomy (OMC):
- No open heart surgery, no sternotomy, no cardiopulmonary bypass
- Shorter hospital stay, faster recovery
- Comparable efficacy to OMC for suitable morphology (Wilkins score ≤8)
- Can be performed safely during pregnancy (avoiding teratogenic risks of heart-lung bypass)
- Repeatable if restenosis occurs (open surgery is generally not repeatable)
Inoue Balloon: Self-positioning balloon that inflates sequentially — distal portion first (fixes balloon in position), then proximal portion, finally middle (dilating force). Now available in various sizes (24–30 mm).
Artificial intelligence applied to echocardiography is an emerging advance:
- Automated RHD detection from echocardiographic images by non-expert health workers using handheld portable echo devices — enables scaling of screening programs in resource-limited settings
- AI algorithms trained on WHF criteria can detect pathological MR/AR with sensitivity and specificity approaching cardiologist-level assessment
- This could transform population-level screening in Sub-Saharan Africa, South Asia, and Pacific Island nations where RHD remains endemic and cardiologists are scarce
No licensed GAS vaccine currently exists, but it remains a major research priority. Challenges include:
- Over 200 GAS M-protein serotypes — multivalent vaccine complexity
- Risk of molecular mimicry — vaccine must avoid epitopes that cross-react with cardiac antigens
- Current candidates under development: M-protein–based multivalent vaccines and conserved GAS antigen vaccines (SpyCEP, SpyAD)
- A successful GAS vaccine would achieve primordial prevention — eliminating ARF and RHD before the strep-ARF pathway is ever triggered
The Ozaki procedure (aortic valve neocuspidization) involves reconstructing the aortic valve using the patient's own pericardium (autologous, glutaraldehyde-treated), tailored to precise measurements. It avoids a mechanical or bioprosthetic prosthetic valve.
Relevance in RHD: In children and young adults with rheumatic aortic valve disease requiring surgery, the Ozaki technique offers the advantage of no lifelong anticoagulation (unlike mechanical valves), and potentially superior durability over bioprosthetic valves in young patients. Emerging use in pediatric RHD in high-burden countries.
⚡ Key Points — Quick Revision
One-Liners for Exam
- Organism: GABHS (Group A Beta-Hemolytic Streptococcus / Streptococcus pyogenes)
- Classic teaching: "RF licks the joints, bites the heart" — arthritis is self-limiting; carditis is permanent
- Diagnosis: 2015 Jones criteria — 2 major OR 1 major + 2 minor + evidence of preceding GABHS infection
- Major criteria (mnemonic CASES): Carditis, Arthritis, Sydenham's chorea, Erythema marginatum, Subcutaneous nodules
- Subclinical carditis: Echo-detected MR/AR without murmur — now a major criterion (2015)
- Most common valve affected: Mitral (alone in 50–60%)
- Acute ARF → MR: Regurgitation first (valve inflammation). Chronic RHD → MS: Stenosis later (fibrosis and fusion)
- Murmur of MS: Loud S1 + Opening Snap + Low-pitched rumbling MDM at apex (LLD, bell) + PSA (absent in AF)
- Carey-Coombs murmur: MDM in active ARF (active valvulitis) — transient, no OS, soft S1
- Graham-Steell murmur: Functional PR from severe PAH due to MS — at left upper sternal border
- Malar flush: Classic sign of severe MS (chronic hypoxia → malar capillary dilation)
- S2-OS interval: Shorter = more severe MS (higher LA pressure)
- Gold standard investigation: 2D Echo with Color Doppler
- MVA: Normal 4–6 cm² | Mild MS >1.5 | Moderate 1.0–1.5 | Severe <1.0 cm²
- BMV (PTMC): Procedure of choice for symptomatic severe MS with favorable morphology (Wilkins ≤8), no LA thrombus, no significant MR
- Wilkins score >8: Unfavorable for BMV → surgical valve replacement
- Secondary prophylaxis drug: Benzathine Penicillin G 1.2M units IM every 4 weeks
- Duration (RHD + valve disease): 10 years from last attack OR until age 40 (whichever longer)
- IE prophylaxis in RHD: NOT routinely recommended — only for prosthetic valve/previous IE
- Warfarin indication in RHD: MS + AF, prior embolism, or LA thrombus (INR 2–3)
- Chorea management: Sodium valproate/carbamazepine + mandatory secondary prophylaxis
📊 Quick Comparison: MDM Causes at Apex
| Cause | Key Feature |
|---|---|
| Mitral Stenosis (RHD) | Loud S1, OS present, PSA (absent in AF), MDM |
| Carey-Coombs (ARF) | Soft S1, No OS, No PSA, active carditis context, transient |
| Austin Flint (AR) | AR murmur present, wide pulse pressure, peripheral AR signs |
| Large VSD (flow) | PSM at LLSB present, signs of VSD/CHD in infant |
| Large ASD (flow) | Wide fixed split S2, pulmonary systolic murmur |